P2293
A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937)6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)Asenapine in the Treatment of Older Adults With Bipolar DisorderInvestigator Initiated Study - Asenapine Early PsychosisOnce-Daily Asenapine for SchizophreniaAn Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)
P4844
Asenapine: a clinical review of a second-generation antipsychoticQuantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects.Asenapine: a synthesis of efficacy data in bipolar mania and schizophrenia.Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses.Combination therapy for manic phases: a critical review of a common practice.Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.[Asenapine in bipolar disorder: efficacy, safety and place in clinical practice].Iloperidone, asenapine and lurasidone: a primer on their current status.Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administrationInteractions between antiepileptics and second-generation antipsychotics.The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia.Stability-indicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation.Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine.Asenapine for elderly bipolar manic patients.Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia.Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.Asenapine: a new antipsychotic option.Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis.Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study.Development and validation of automated SPE-HPLC-MS/MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urineValproate reduces the glucuronidation of asenapine without affecting asenapine plasma concentrations▼Asenapine for bipolar I disorder?
P921
Q61936009-ED58EFE3-3BE9-4F61-B158-0F4D69D70024Q61936353-FDB918ED-613B-4989-9B4C-B2FC595E8E79Q61965715-8BE3794D-B9F7-4A89-A916-A9BFCF7391D1Q61975534-2FB1D4C0-C093-4512-AD83-7EEB82356B01Q63316250-B3E9E107-E08E-4533-899A-1DD8A184E399Q63318336-B8343795-940B-45CD-B7D1-B3C365E1C9EAQ63319332-5787A1CF-B86D-471F-82AE-262C6134AC06Q63335021-68A991E6-B6EE-4CB9-AEC4-186F36D62CEE
P4844
description
Lääke
@fi
drug
@en
mieszanina racemiczna
@pl
substance active d'un médicament
@es
name
Asenapiini
@fi
Asenapin
@da
Asenapin
@de
Asenapin
@sh
Asenapin
@sr
Asenapin
@sr-el
Asenapin
@sv
Asenapine
@vi
asenapin
@nn
asenapina
@pl
type
label
Asenapiini
@fi
Asenapin
@da
Asenapin
@de
Asenapin
@sh
Asenapin
@sr
Asenapin
@sr-el
Asenapin
@sv
Asenapine
@vi
asenapin
@nn
asenapina
@pl
altLabel
ATC kod N05AH05
@sr
ATCvet kod QN05AH05
@sr
Asenapine
@pt
C17H16ClNO
@sr
Safris
@sr
Saphris
@sr
Sikrest
@sr
Sycrest
@sr
prefLabel
Asenapiini
@fi
Asenapin
@da
Asenapin
@de
Asenapin
@sh
Asenapin
@sr
Asenapin
@sr-el
Asenapin
@sv
Asenapine
@vi
asenapin
@nn
asenapina
@pl
P6366
P646
P683
P2275
asenapine
@en
P231
65576-45-6
P232
P2566
100.059.828
P267
P3345
P6366
2779626651
P646
/m/0264jhb